CHRO compensation in PE-backed portfolios: 2026

The 2026 picture for portfolio CHRO compensation is meaningfully different from the 2024 baseline. Cash has moved up, but not as much as the market commentary suggests. The long-term incentive structure has shifted more substantively, with co-invest and direct deal economics replacing the sweat-equity and shadow-equity arrangements of the previous cycle. The deferred element, in particular the second-bite structure, is the part most sponsors are still pricing badly.

The headline read: a portfolio CHRO offer that would have been competitive in 2024 is, in most fund and sector configurations, no longer competitive in 2026. The gap is not vast, but it is consistent enough that the offers we are seeing get declined are typically declined for one of three predictable pricing reasons.

The cash baseline

Base salary bands have moved roughly in line with senior executive inflation across the comparable PE-backed portfolio universe, with regional variation. The bands below reflect what JOH Partners has placed across the 2024 to Q1 2026 mandate book, normalised to USD and segmented by portfolio company revenue size.

Figure 01FIG-01

Portfolio CHRO base salary bands by company size

USD k, base only

Portfolio company revenue	MENA portfolio	UK and Western Europe	US
Under $200M	280 to 420	240 to 360	280 to 400
$200M to $1B	400 to 650	360 to 560	420 to 700
Over $1B	600 to 900	540 to 820	700 to 1,100

Three observations on the cash baseline that are worth saying directly.

First, the MENA premium at the top end is real and is roughly fifteen to twenty-five percent over the equivalent UK or Western European band, depending on the geography of the role and the international relocation expectation. The premium narrows substantially at the lower end of the small-cap band; it widens at the top end of the large-cap band. The premium is, in our experience, defensible: the GCC senior HR pool with credible PE-portfolio experience is structurally smaller than the UK or Western European pool, and the relocation friction is higher.

Second, the US bands run higher than the comparable MENA or UK bands at the large-cap end. For dual-listed groups, or US-headquartered portfolio companies under European sponsor ownership, the offer structure tends to be benchmarked against the US base, which produces a different conversation about target bonus mix and LTI weight.

Third, the bands above describe cash base only. They are not the offer. The offer, in the 2026 PE portfolio market, is increasingly the LTI and the deferred element rather than the base. Sponsors who run the conversation as a base-salary conversation are usually the ones who lose the candidate at the offer stage.

The LTI shift

The structural change in portfolio CHRO compensation through 2024 and 2025 has been the migration from shadow-equity and sweat-equity arrangements toward direct co-invest exposure and, in a smaller cohort, carry pool participation.

In 2020, the portfolio CHRO with direct co-invest in the deal was the exception rather than the rule. In our placement data from that year, roughly one in eight CHRO placements involved direct co-invest. By 2024, that figure had moved to roughly one in three. By Q1 2026, it sits at roughly thirty-eight percent of the placements we have run since the start of 2024, and it is the modal expectation in the negotiation we now run with experienced portfolio CHRO candidates.

Figure 02FIG-02

LTI structure for portfolio CHROs, 2020 vs 2026

% of CHRO placements

LTI mechanism	2020 share	2026 share
Direct co-invest in the deal	12%	38%
Carry pool participation (mid-market funds)	6%	14%
Shadow equity / phantom equity	41%	22%
Sweat equity (vesting on exit)	28%	16%
Cash-based LTIP (no equity exposure)	13%	10%

The shift from shadow equity to direct co-invest is the substantive change. Shadow equity, in many of the configurations we have seen, was a notional instrument that produced a notional outcome at exit. Direct co-invest is real cash in, real economics out, with the candidate's exposure aligned with the sponsor's and the rest of the management team's. The structural integrity of the alignment is materially higher.

Carry pool participation for portfolio CHROs remains less common than direct co-invest, but the cohort that holds it is growing. In the mid-market sponsor universe in particular, where the operating-partner model has matured, the senior portfolio HR leaders are increasingly being given basis-point exposure to the fund's carry pool rather than, or alongside, deal-level co-invest. The basis-point ranges we are seeing for portfolio CHROs sit in the five to fifteen basis point range in mid-market funds, with the larger funds running smaller percentages but materially larger absolute cash exposures.

Deferred and retention

The deferred element of the offer is the part most sponsors still treat as standard boilerplate. In 2026, it is the part that most often determines whether the offer gets accepted.

The second-bite structure, which formalises a sign-on cash element, a multi-year retention design, and a claw-back provision tied to the exit-aligned bonus, is becoming standard at the senior end of the market. The exit-aligned bonus, separate from the LTI, is increasingly priced as a function of the expected hold period and the candidate's pre-exit compensation foregone.

What is becoming standard: a sign-on cash element calibrated against the variable element foregone at the previous role; a retention design that vests progressively across the expected hold period rather than cliff-vesting at exit; a claw-back provision tied to retention rather than performance.

What remains genuinely negotiable: the size of the sign-on relative to the foregone variable; the specific vesting schedule; whether the retention design includes a partial cash payout at the mid-point of the hold period or is fully back-end loaded; whether the claw-back applies to the LTI as well as the retention element.

The mistake sponsors make on the second bite is treating it as housekeeping. By the time the candidate has finished the first read of the offer, they have already priced the second bite into their reservation number. If the second bite is wrong, the offer is already declining.

The reason the second-bite structure is the most commonly underpriced element of the offer is that it is, by definition, the element that the sponsor pays only on a successful outcome. Sponsors therefore price it from a confidence-of-success perspective rather than a candidate-incentive perspective. The candidate, who carries the optionality risk, prices it from the opposite perspective. The two perspectives converge cleanly when the second bite is sized to be materially larger than the foregone equity at the previous role; they diverge when it is sized to match.

Three pricing mistakes sponsors still make

The three mistakes below are the ones that, in our negotiation experience, account for most of the offers that get declined or that fill but fail at twenty-four months.

Anchoring to the last role's package instead of pricing for the next role's risk

The first and most common mistake is the anchoring mistake. The sponsor compares the candidate's current cash plus current LTI plus current deferred to the proposed offer, finds the proposed offer is competitive against the comparison, and considers the pricing question closed. The candidate, who is being asked to leave a role with known economics for a role with unknown economics across a multi-year hold period, prices in the optionality risk on top of the comparison. The two prices are not the same.

The right pricing posture is to acknowledge the optionality risk explicitly and price the offer as a function of it. Roles in earlier-stage portfolio companies, where the exit timing is more uncertain, price higher than roles in later-stage portfolio companies where the exit timing is more visible. Roles in turnaround portfolio companies price higher than roles in steady-state portfolio companies. Roles where the candidate is leaving a public-company offer price higher than roles where the candidate is leaving a private-company offer.

Underweighting the second-bite when the first exit is plausibly three or more years away

The second mistake is the time-discounting mistake. Sponsors who model an eighteen-to-twenty-four-month hold can underweight the second-bite without much consequence; the offer is fundamentally about the first exit and the candidate prices accordingly. Sponsors who, more honestly, model a thirty-six-to-forty-eight-month hold and still underweight the second-bite are mispricing.

The candidate at the senior portfolio CHRO level knows that the meaningful economics on a three-to-four-year hold come at the back end. They also know that the back end is where the optionality on the sponsor's exit timing matters most. The second-bite, sized appropriately, is the element that compensates for that optionality.

Treating CHRO comp as an HR line item rather than as a strategic offer

The third mistake is the most cultural. In a small but persistent number of sponsor configurations, the portfolio CHRO offer is run by the portfolio company's existing HR function rather than by the sponsor's deal-side or operating-partner team. The result is that the offer is benchmarked against the portfolio company's existing senior compensation rather than against the sponsor's portfolio CHRO market.

This is structurally backwards. The portfolio CHRO is not a senior member of the existing HR function; the portfolio CHRO is the senior leader who is going to redesign the HR function in service of the value-creation thesis. Pricing the offer against the existing senior compensation is pricing the wrong role.

The sponsors who get this right, in our experience, run the portfolio CHRO offer through the deal-side or operating-partner team, benchmark it against the comparable portfolio CHRO market in the relevant geography, and treat it as a strategic talent decision rather than as an HR replacement decision.

The right offer, 2026

The right portfolio CHRO offer in 2026 has a recognisable shape. The cash base sits inside the relevant size and geography band. The LTI weights direct co-invest as the primary mechanism, with carry pool participation where the sponsor structure makes that available. The second-bite structure is sized as a function of the foregone variable at the previous role plus a premium for the optionality risk. The deferred elements are vested progressively across the expected hold rather than back-end loaded. The claw-back is tied to retention, not to performance.

The shape is not exotic. It is the shape of an offer that has been priced from the candidate's reservation perspective rather than from the sponsor's housekeeping perspective. The sponsors that run it this way close their CHRO mandates faster, retain their CHRO appointments longer, and pay, in aggregate across the fund's portfolio CHRO population, less rather than more. The sponsors that do not run it this way pay more, twice: once on the offers they have to re-price after the first round of declines, and once on the replacement searches at twenty-four months.

The five questions above will not produce a perfect offer. They will produce, with reasonable consistency, an offer that the candidate at the senior end of the portfolio CHRO market reads as serious. In the 2026 market, where the comparable candidate has multiple offers and the sponsor's negotiation window is short, that is the threshold the offer has to clear.

---

JOH Partners runs portfolio leadership mandates across investments and private-equity-backed portfolio companies in MENA, the UK and Singapore. For confidential conversations on portfolio CHRO and other senior portfolio briefs, contact the partners directly.